Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
MDGL
#778
Madrigal Pharmaceuticals, Inc. Common Stock
432.000
0
-0.54%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-0.54%
Monatliche Änderung
-14.35%
6 month change
+1.98%
Jahresänderung
+1.98%
Vorheriger Schlusskurs
434.360
0
Open
432.000
0
Bid
Ask
Low
432.000
0
High
432.000
0
Volumen
139
Märkte
Aktien
Gesundheitswesen
MDGL
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
21.81 M
22.08 M
22.2 M
22.29 M
22.71 M
22.94 M
—
Valuation ratios
Enterprise value
4.4 B
6.71 B
7.17 B
6.56 B
10.12 B
13.16 B
37.01 B
Price to earnings ratio
-8.44
-14.09
-18.57
-23.94
-35.83
-45.32
-123.66
Price to sales ratio
59.9
36.44
22.67
12.87
13.72
13.63
62.89
Price to cash flow ratio
10.05
14.41
18.08
21.41
61.13
68.92
169.55
Price to book ratio
1.52
8.7
2.31
2.25
3.62
21.68
29.85
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.1
0.06
0.07
0.04
0.08
0.05
0.25
Return on equity %
0.14
0.08
0.1
0.06
0.18
0.1
0.44
Return on invested capital %
—
-4 924.84
—
—
—
1 405.04
—
Gross margin %
100
100
96.71
100
100
100
396.71
Operating margin %
187.06
64.84
57.79
22.18
39.68
18.56
138.21
EBITDA margin %
—
—
-60.8
—
—
—
—
Net margin %
172.04
57.51
53.36
19.87
39.75
18.24
131.22
Liquidity ratios
Quick ratio
5.93
5.9
5.58
4.78
3.26
3.77
17.4
Current ratio
5.98
6.1
5.91
5.11
3.44
4.01
18.47
Inventory turnover
—
—
0.1
—
—
—
—
Asset turnover
0.06
0.1
0.13
0.21
0.24
0.24
0.83
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.11
0.11
0.12
0.12
0.25
0.27
0.75
Long term debt to total equity ratio
0.15
0.16
0.17
0.17
0.54
0.56
1.44
Per share metrics
Operating cash flow per share
3.08
4.91
4.02
2.12
-3.55
5.95
8.54
EBIT per share
—
—
-3.79
—
—
—
—
EBITDA per share
—
—
-3.78
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
46.15
43.78
38.39
36.12
49.58
43.84
167.93
Net current asset value per share
48.91
48.56
44.72
45.18
59.9
55.53
205.33
Tangible book value per share
35.52
35.24
31.96
31.14
27.5
26.54
117.13
Working capital per share
40.73
40.6
37.15
36.33
42.49
41.7
157.67
Book value per share
35.74
35.46
32.17
31.34
27.83
26.86
118.21
Nachrichten
Madrigal: The Easiest Money May Have Been Made (NASDAQ:MDGL)
Novo Nordisk Stock: Why Wegovy Growth Beats Wall Street Expectations (NYSE:NVO)
H.C. Wainwright bekräftigt Kaufempfehlung für Madrigal – Aktie trotz Kursrückgang unterbewertet
H.C. Wainwright reiterates Madrigal Pharmaceuticals stock rating at buy
Madrigal Q4 Earnings Miss, MASH Drug Sales Drive Top Line, Stock Down
Lam Research, Goldman Sachs among market cap stock movers on Thursday
Madrigal Pharmaceuticals, Inc. (MDGL) Q4 2025 Earnings Call Transcript
Oracle, Deere among market cap stock movers on Thursday
Madrigal: Starker Rezdiffra-Umsatz kann deutliche Gewinnverfehlung nicht ausgleichen
Madrigal Q4 2025 slides: Rezdiffra nears $1B in first year sales despite EPS miss
Madrigal (MDGL) Reports Q4 Loss, Beats Revenue Estimates
Madrigal Pharma: Quartalsverlust überschattet Umsatzplus – Aktie fällt um über 5 %